+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06746883

Observational Study to Evaluate Safety and Risk of Allergic Reactions from Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus Complex Infection

Led by Innoviva Specialty Therapeutics · Updated on 2026-06-24

100

Participants Needed

12

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This observational study aims to evaluate the safety of sulbactam-durlobactam and the risk of hypersensitivity reactions, including anaphylaxis, in adults with infections caused by the Acinetobacter baumannii-calcoaceticus complex. The study focuses on hospitalized participants who have a proven or strongly suspected ABC infection and are treated with sulbactam-durlobactam as part of their standard care. Participants will be observed for approximately 28 days to collect safety data related to treatment-emergent adverse events and hypersensitivity reactions. The study does not involve administering the treatment but monitors participants receiving sulbactam-durlobactam through routine clinical care. Data on liver function, vital signs, blood counts, and electrocardiogram QT measurements will also be collected at baseline and day 28. During the study, participants will be followed closely to record any adverse events and changes in clinical parameters. Researchers will measure the frequency, severity, and relatedness of adverse events and hypersensitivity reactions over the 28-day period. The study also tracks changes from baseline in various laboratory and vital sign measures to understand the safety profile of sulbactam-durlobactam in this patient group.

CONDITIONS

Brief Title

A Study to Assess the Safety and Risk of Hypersensitivity Reactions of Sulbactam-durlobactam in Adults With Acinetobacter Baumannii-calcoaceticus (ABC) Complex Infection

Research Team

R

Reddy Tummala ISTX Clinical Trials

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here